Shorts

Anagrelide: Platelet-Reducing Agent for Cancer-Related Thrombocytosis

Addressing the Unmet Need in Migraine Prevention

Wegovy HD: High-Dose Semaglutide for Greater Weight Loss

Pharmacy Technicians Serve as a Critical Safety Check in Clinical Practice

Sevabertinib: Kinase Inhibitor for Non-Small Cell Lung Cancer

Pneumococcal Disease Insights: Why Vaccination Matters

Doravirine/Islatravir: New Once-Daily HIV Combination

Understanding the Link Between Hunger and Brain Health

Lerodalcibep: Monthly PCSK9 Inhibitor to Lower LDL

What Oncology Pharmacists Value Most About the COA Conference

Lumateperone: One Capsule, Three Psychiatric Indications

New Trump EO Bolsters Psychedelics Space

Pharmacists Want Pulse by NABP Scanning Tool: "It's Not How, It's When"

Saro's Scripts: Suzetrigine

Why Reducing Proteinuria Can Lower Your Risk of Kidney Disease

Saro's Scripts: Olezarsen

New Dyslipidemia Guidelines are Here

Advancing Innovation in Community Oncology Through Collaborative Care

Innovation in Focus: What’s Ahead at COA 2026

Saro's Scripts: Donanemab

What to Expect at COA 2026: Key Trends in Community Oncology

Saro's Scripts: SGLT2 Inhibitors

Expanding Access to Innovative Cancer Therapies in Community Oncology

What Teplizumab's FDA Approval Means for Pharmacists

Saro's Scripts: Orforglipron

Why NABP's English Proficiency Exam Uses Computer-Based Speaking Tests Over Live Conversations

Saro's Scripts: Insulin Icodec Offers a New Long-Acting Basal Insulin Option

How Pulse by NABP Is Strengthening Pharmaceutical Supply Chain Investigations

New Difamilast Ointment for Atopic Dermatitis

Global Perspectives: Top Takeaways from the Sports Pharmacy Summit